 | • レポートコード：MRC2-11QY01551 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は免疫グロブリンのグローバル市場について調査・分析したレポートです。種類別（筋肉内注射ヒト免疫グロブリン、静脈内注射ヒト免疫グロブリン）市場規模、用途別（はしか予防、感染性肝炎、原発性免疫グロブリン欠乏症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別免疫グロブリンの競争状況、市場シェア ・世界の免疫グロブリン市場：種類別市場規模 2015年-2020年（筋肉内注射ヒト免疫グロブリン、静脈内注射ヒト免疫グロブリン） ・世界の免疫グロブリン市場：種類別市場規模予測 2021年-2026年（筋肉内注射ヒト免疫グロブリン、静脈内注射ヒト免疫グロブリン） ・世界の免疫グロブリン市場：用途別市場規模 2015年-2020年（はしか予防、感染性肝炎、原発性免疫グロブリン欠乏症） ・世界の免疫グロブリン市場：用途別市場規模予測 2021年-2026年（はしか予防、感染性肝炎、原発性免疫グロブリン欠乏症） ・北米の免疫グロブリン市場分析：米国、カナダ ・ヨーロッパの免疫グロブリン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの免疫グロブリン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の免疫グロブリン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの免疫グロブリン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Baxter、CSL、Grifols、Octapharma、Biotest、China National Pharmaceutical Group、CTBB、Hualan Bio、RAAS、Shanxi Kangbao Biological、Shuanglin Bio Pharm、Sichuan Yuanda Shuyang Pharmaceutical、Boya Bio、Jiade Bio、Weilun Bio ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Immunoglobulin Market
The global Immunoglobulin market size is projected to reach US$ 9025.1 million by 2026, from US$ 8538.2 million in 2020, at a CAGR of 5.3%% during 2021-2026.
Global Immunoglobulin Scope and Market Size
Immunoglobulin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunoglobulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Immunoglobulin market is segmented into
Intramuscular Injection Human Immunoglobulin
Intravenous Injection Human Immunoglobulin
Segment by Application, the Immunoglobulin market is segmented into
Prevention Of Measles
Infectious Hepatitis
Primary Immunoglobulin Deficiency
Regional and Country-level Analysis
The Immunoglobulin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Immunoglobulin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Immunoglobulin Market Share Analysis
Immunoglobulin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Immunoglobulin business, the date to enter into the Immunoglobulin market, Immunoglobulin product introduction, recent developments, etc.
The major vendors covered:
Baxter
CSL
Grifols
Octapharma
Biotest
China National Pharmaceutical Group
CTBB
Hualan Bio
RAAS
Shanxi Kangbao Biological
Shuanglin Bio Pharm
Sichuan Yuanda Shuyang Pharmaceutical
Boya Bio
Jiade Bio
Weilun Bio
1 Study Coverage
1.1 Immunoglobulin Product Introduction
1.2 Market Segments
1.3 Key Immunoglobulin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Immunoglobulin Market Size Growth Rate by Type
1.4.2 Intramuscular Injection Human Immunoglobulin
1.4.3 Intravenous Injection Human Immunoglobulin
1.5 Market by Application
1.5.1 Global Immunoglobulin Market Size Growth Rate by Application
1.5.2 Prevention Of Measles
1.5.3 Infectious Hepatitis
1.5.4 Primary Immunoglobulin Deficiency
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Immunoglobulin Market Size, Estimates and Forecasts
2.1.1 Global Immunoglobulin Revenue 2015-2026
2.1.2 Global Immunoglobulin Sales 2015-2026
2.2 Global Immunoglobulin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Immunoglobulin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Immunoglobulin Competitor Landscape by Players
3.1 Immunoglobulin Sales by Manufacturers
3.1.1 Immunoglobulin Sales by Manufacturers (2015-2020)
3.1.2 Immunoglobulin Sales Market Share by Manufacturers (2015-2020)
3.2 Immunoglobulin Revenue by Manufacturers
3.2.1 Immunoglobulin Revenue by Manufacturers (2015-2020)
3.2.2 Immunoglobulin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Immunoglobulin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Immunoglobulin Revenue in 2019
3.2.5 Global Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Immunoglobulin Price by Manufacturers
3.4 Immunoglobulin Manufacturing Base Distribution, Product Types
3.4.1 Immunoglobulin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immunoglobulin Product Type
3.4.3 Date of International Manufacturers Enter into Immunoglobulin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immunoglobulin Market Size by Type (2015-2020)
4.1.1 Global Immunoglobulin Sales by Type (2015-2020)
4.1.2 Global Immunoglobulin Revenue by Type (2015-2020)
4.1.3 Immunoglobulin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Immunoglobulin Market Size Forecast by Type (2021-2026)
4.2.1 Global Immunoglobulin Sales Forecast by Type (2021-2026)
4.2.2 Global Immunoglobulin Revenue Forecast by Type (2021-2026)
4.2.3 Immunoglobulin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Immunoglobulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Immunoglobulin Market Size by Application (2015-2020)
5.1.1 Global Immunoglobulin Sales by Application (2015-2020)
5.1.2 Global Immunoglobulin Revenue by Application (2015-2020)
5.1.3 Immunoglobulin Price by Application (2015-2020)
5.2 Immunoglobulin Market Size Forecast by Application (2021-2026)
5.2.1 Global Immunoglobulin Sales Forecast by Application (2021-2026)
5.2.2 Global Immunoglobulin Revenue Forecast by Application (2021-2026)
5.2.3 Global Immunoglobulin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Immunoglobulin by Country
6.1.1 North America Immunoglobulin Sales by Country
6.1.2 North America Immunoglobulin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Immunoglobulin Market Facts & Figures by Type
6.3 North America Immunoglobulin Market Facts & Figures by Application
7 Europe
7.1 Europe Immunoglobulin by Country
7.1.1 Europe Immunoglobulin Sales by Country
7.1.2 Europe Immunoglobulin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Immunoglobulin Market Facts & Figures by Type
7.3 Europe Immunoglobulin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Immunoglobulin by Region
8.1.1 Asia Pacific Immunoglobulin Sales by Region
8.1.2 Asia Pacific Immunoglobulin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Immunoglobulin Market Facts & Figures by Type
8.3 Asia Pacific Immunoglobulin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Immunoglobulin by Country
9.1.1 Latin America Immunoglobulin Sales by Country
9.1.2 Latin America Immunoglobulin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Immunoglobulin Market Facts & Figures by Type
9.3 Central & South America Immunoglobulin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Immunoglobulin by Country
10.1.1 Middle East and Africa Immunoglobulin Sales by Country
10.1.2 Middle East and Africa Immunoglobulin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Immunoglobulin Market Facts & Figures by Type
10.3 Middle East and Africa Immunoglobulin Market Facts & Figures by Application
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description and Business Overview
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Immunoglobulin Products Offered
11.1.5 Baxter Related Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Description and Business Overview
11.2.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CSL Immunoglobulin Products Offered
11.2.5 CSL Related Developments
11.3 Grifols
11.3.1 Grifols Corporation Information
11.3.2 Grifols Description and Business Overview
11.3.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Grifols Immunoglobulin Products Offered
11.3.5 Grifols Related Developments
11.4 Octapharma
11.4.1 Octapharma Corporation Information
11.4.2 Octapharma Description and Business Overview
11.4.3 Octapharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Octapharma Immunoglobulin Products Offered
11.4.5 Octapharma Related Developments
11.5 Biotest
11.5.1 Biotest Corporation Information
11.5.2 Biotest Description and Business Overview
11.5.3 Biotest Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biotest Immunoglobulin Products Offered
11.5.5 Biotest Related Developments
11.6 China National Pharmaceutical Group
11.6.1 China National Pharmaceutical Group Corporation Information
11.6.2 China National Pharmaceutical Group Description and Business Overview
11.6.3 China National Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
11.6.4 China National Pharmaceutical Group Immunoglobulin Products Offered
11.6.5 China National Pharmaceutical Group Related Developments
11.7 CTBB
11.7.1 CTBB Corporation Information
11.7.2 CTBB Description and Business Overview
11.7.3 CTBB Sales, Revenue and Gross Margin (2015-2020)
11.7.4 CTBB Immunoglobulin Products Offered
11.7.5 CTBB Related Developments
11.8 Hualan Bio
11.8.1 Hualan Bio Corporation Information
11.8.2 Hualan Bio Description and Business Overview
11.8.3 Hualan Bio Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Hualan Bio Immunoglobulin Products Offered
11.8.5 Hualan Bio Related Developments
11.9 RAAS
11.9.1 RAAS Corporation Information
11.9.2 RAAS Description and Business Overview
11.9.3 RAAS Sales, Revenue and Gross Margin (2015-2020)
11.9.4 RAAS Immunoglobulin Products Offered
11.9.5 RAAS Related Developments
11.10 Shanxi Kangbao Biological
11.10.1 Shanxi Kangbao Biological Corporation Information
11.10.2 Shanxi Kangbao Biological Description and Business Overview
11.10.3 Shanxi Kangbao Biological Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Shanxi Kangbao Biological Immunoglobulin Products Offered
11.10.5 Shanxi Kangbao Biological Related Developments
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description and Business Overview
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Immunoglobulin Products Offered
11.1.5 Baxter Related Developments
11.12 Sichuan Yuanda Shuyang Pharmaceutical
11.12.1 Sichuan Yuanda Shuyang Pharmaceutical Corporation Information
11.12.2 Sichuan Yuanda Shuyang Pharmaceutical Description and Business Overview
11.12.3 Sichuan Yuanda Shuyang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Sichuan Yuanda Shuyang Pharmaceutical Products Offered
11.12.5 Sichuan Yuanda Shuyang Pharmaceutical Related Developments
11.13 Boya Bio
11.13.1 Boya Bio Corporation Information
11.13.2 Boya Bio Description and Business Overview
11.13.3 Boya Bio Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Boya Bio Products Offered
11.13.5 Boya Bio Related Developments
11.14 Jiade Bio
11.14.1 Jiade Bio Corporation Information
11.14.2 Jiade Bio Description and Business Overview
11.14.3 Jiade Bio Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Jiade Bio Products Offered
11.14.5 Jiade Bio Related Developments
11.15 Weilun Bio
11.15.1 Weilun Bio Corporation Information
11.15.2 Weilun Bio Description and Business Overview
11.15.3 Weilun Bio Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Weilun Bio Products Offered
11.15.5 Weilun Bio Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Immunoglobulin Market Estimates and Projections by Region
12.1.1 Global Immunoglobulin Sales Forecast by Regions 2021-2026
12.1.2 Global Immunoglobulin Revenue Forecast by Regions 2021-2026
12.2 North America Immunoglobulin Market Size Forecast (2021-2026)
12.2.1 North America: Immunoglobulin Sales Forecast (2021-2026)
12.2.2 North America: Immunoglobulin Revenue Forecast (2021-2026)
12.2.3 North America: Immunoglobulin Market Size Forecast by Country (2021-2026)
12.3 Europe Immunoglobulin Market Size Forecast (2021-2026)
12.3.1 Europe: Immunoglobulin Sales Forecast (2021-2026)
12.3.2 Europe: Immunoglobulin Revenue Forecast (2021-2026)
12.3.3 Europe: Immunoglobulin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Immunoglobulin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Immunoglobulin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Immunoglobulin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Immunoglobulin Market Size Forecast by Region (2021-2026)
12.5 Latin America Immunoglobulin Market Size Forecast (2021-2026)
12.5.1 Latin America: Immunoglobulin Sales Forecast (2021-2026)
12.5.2 Latin America: Immunoglobulin Revenue Forecast (2021-2026)
12.5.3 Latin America: Immunoglobulin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Immunoglobulin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Immunoglobulin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Immunoglobulin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Immunoglobulin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Immunoglobulin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Immunoglobulin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Immunoglobulin Market Segments
Table 2. Ranking of Global Top Immunoglobulin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Immunoglobulin Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Intramuscular Injection Human Immunoglobulin
Table 5. Major Manufacturers of Intravenous Injection Human Immunoglobulin
Table 6. Global Immunoglobulin Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Immunoglobulin Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Immunoglobulin Sales by Regions 2015-2020 (K Units)
Table 9. Global Immunoglobulin Sales Market Share by Regions (2015-2020)
Table 10. Global Immunoglobulin Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Immunoglobulin Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Immunoglobulin Sales Share by Manufacturers (2015-2020)
Table 13. Global Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunoglobulin as of 2019)
Table 15. Immunoglobulin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Immunoglobulin Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Immunoglobulin Price (2015-2020) (USD/Unit)
Table 18. Immunoglobulin Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Immunoglobulin Product Type
Table 20. Date of International Manufacturers Enter into Immunoglobulin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 23. Global Immunoglobulin Sales Share by Type (2015-2020)
Table 24. Global Immunoglobulin Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Immunoglobulin Revenue Share by Type (2015-2020)
Table 26. Immunoglobulin Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 28. Global Immunoglobulin Sales Share by Application (2015-2020)
Table 29. North America Immunoglobulin Sales by Country (2015-2020) (K Units)
Table 30. North America Immunoglobulin Sales Market Share by Country (2015-2020)
Table 31. North America Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 33. North America Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 34. North America Immunoglobulin Sales Market Share by Type (2015-2020)
Table 35. North America Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 36. North America Immunoglobulin Sales Market Share by Application (2015-2020)
Table 37. Europe Immunoglobulin Sales by Country (2015-2020) (K Units)
Table 38. Europe Immunoglobulin Sales Market Share by Country (2015-2020)
Table 39. Europe Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 41. Europe Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 42. Europe Immunoglobulin Sales Market Share by Type (2015-2020)
Table 43. Europe Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 44. Europe Immunoglobulin Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Immunoglobulin Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Immunoglobulin Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Immunoglobulin Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Immunoglobulin Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Immunoglobulin Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Immunoglobulin Sales Market Share by Application (2015-2020)
Table 53. Latin America Immunoglobulin Sales by Country (2015-2020) (K Units)
Table 54. Latin America Immunoglobulin Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 57. Latin America Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 58. Latin America Immunoglobulin Sales Market Share by Type (2015-2020)
Table 59. Latin America Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 60. Latin America Immunoglobulin Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Immunoglobulin Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Immunoglobulin Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Immunoglobulin Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Immunoglobulin Sales Market Share by Application (2015-2020)
Table 69. Baxter Corporation Information
Table 70. Baxter Description and Major Businesses
Table 71. Baxter Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Baxter Product
Table 73. Baxter Recent Development
Table 74. CSL Corporation Information
Table 75. CSL Description and Major Businesses
Table 76. CSL Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. CSL Product
Table 78. CSL Recent Development
Table 79. Grifols Corporation Information
Table 80. Grifols Description and Major Businesses
Table 81. Grifols Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Grifols Product
Table 83. Grifols Recent Development
Table 84. Octapharma Corporation Information
Table 85. Octapharma Description and Major Businesses
Table 86. Octapharma Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Octapharma Product
Table 88. Octapharma Recent Development
Table 89. Biotest Corporation Information
Table 90. Biotest Description and Major Businesses
Table 91. Biotest Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Biotest Product
Table 93. Biotest Recent Development
Table 94. China National Pharmaceutical Group Corporation Information
Table 95. China National Pharmaceutical Group Description and Major Businesses
Table 96. China National Pharmaceutical Group Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. China National Pharmaceutical Group Product
Table 98. China National Pharmaceutical Group Recent Development
Table 99. CTBB Corporation Information
Table 100. CTBB Description and Major Businesses
Table 101. CTBB Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. CTBB Product
Table 103. CTBB Recent Development
Table 104. Hualan Bio Corporation Information
Table 105. Hualan Bio Description and Major Businesses
Table 106. Hualan Bio Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Hualan Bio Product
Table 108. Hualan Bio Recent Development
Table 109. RAAS Corporation Information
Table 110. RAAS Description and Major Businesses
Table 111. RAAS Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. RAAS Product
Table 113. RAAS Recent Development
Table 114. Shanxi Kangbao Biological Corporation Information
Table 115. Shanxi Kangbao Biological Description and Major Businesses
Table 116. Shanxi Kangbao Biological Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Shanxi Kangbao Biological Product
Table 118. Shanxi Kangbao Biological Recent Development
Table 119. Shuanglin Bio Pharm Corporation Information
Table 120. Shuanglin Bio Pharm Description and Major Businesses
Table 121. Shuanglin Bio Pharm Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Shuanglin Bio Pharm Product
Table 123. Shuanglin Bio Pharm Recent Development
Table 124. Sichuan Yuanda Shuyang Pharmaceutical Corporation Information
Table 125. Sichuan Yuanda Shuyang Pharmaceutical Description and Major Businesses
Table 126. Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Sichuan Yuanda Shuyang Pharmaceutical Product
Table 128. Sichuan Yuanda Shuyang Pharmaceutical Recent Development
Table 129. Boya Bio Corporation Information
Table 130. Boya Bio Description and Major Businesses
Table 131. Boya Bio Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Boya Bio Product
Table 133. Boya Bio Recent Development
Table 134. Jiade Bio Corporation Information
Table 135. Jiade Bio Description and Major Businesses
Table 136. Jiade Bio Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Jiade Bio Product
Table 138. Jiade Bio Recent Development
Table 139. Weilun Bio Corporation Information
Table 140. Weilun Bio Description and Major Businesses
Table 141. Weilun Bio Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Weilun Bio Product
Table 143. Weilun Bio Recent Development
Table 144. Global Immunoglobulin Sales Forecast by Regions (2021-2026) (K Units)
Table 145. Global Immunoglobulin Sales Market Share Forecast by Regions (2021-2026)
Table 146. Global Immunoglobulin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 147. Global Immunoglobulin Revenue Market Share Forecast by Regions (2021-2026)
Table 148. North America: Immunoglobulin Sales Forecast by Country (2021-2026) (K Units)
Table 149. North America: Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Europe: Immunoglobulin Sales Forecast by Country (2021-2026) (K Units)
Table 151. Europe: Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Asia Pacific: Immunoglobulin Sales Forecast by Region (2021-2026) (K Units)
Table 153. Asia Pacific: Immunoglobulin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 154. Latin America: Immunoglobulin Sales Forecast by Country (2021-2026) (K Units)
Table 155. Latin America: Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Middle East and Africa: Immunoglobulin Sales Forecast by Country (2021-2026) (K Units)
Table 157. Middle East and Africa: Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 159. Key Challenges
Table 160. Market Risks
Table 161. Main Points Interviewed from Key Immunoglobulin Players
Table 162. Immunoglobulin Customers List
Table 163. Immunoglobulin Distributors List
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Immunoglobulin Product Picture
Figure 2. Global Immunoglobulin Sales Market Share by Type in 2020 & 2026
Figure 3. Intramuscular Injection Human Immunoglobulin Product Picture
Figure 4. Intravenous Injection Human Immunoglobulin Product Picture
Figure 5. Global Immunoglobulin Sales Market Share by Application in 2020 & 2026
Figure 6. Prevention Of Measles
Figure 7. Infectious Hepatitis
Figure 8. Primary Immunoglobulin Deficiency
Figure 9. Immunoglobulin Report Years Considered
Figure 10. Global Immunoglobulin Market Size 2015-2026 (US$ Million)
Figure 11. Global Immunoglobulin Sales 2015-2026 (K Units)
Figure 12. Global Immunoglobulin Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Immunoglobulin Sales Market Share by Region (2015-2020)
Figure 14. Global Immunoglobulin Sales Market Share by Region in 2019
Figure 15. Global Immunoglobulin Revenue Market Share by Region (2015-2020)
Figure 16. Global Immunoglobulin Revenue Market Share by Region in 2019
Figure 17. Global Immunoglobulin Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Immunoglobulin Revenue in 2019
Figure 19. Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Immunoglobulin Sales Market Share by Type (2015-2020)
Figure 21. Global Immunoglobulin Sales Market Share by Type in 2019
Figure 22. Global Immunoglobulin Revenue Market Share by Type (2015-2020)
Figure 23. Global Immunoglobulin Revenue Market Share by Type in 2019
Figure 24. Global Immunoglobulin Market Share by Price Range (2015-2020)
Figure 25. Global Immunoglobulin Sales Market Share by Application (2015-2020)
Figure 26. Global Immunoglobulin Sales Market Share by Application in 2019
Figure 27. Global Immunoglobulin Revenue Market Share by Application (2015-2020)
Figure 28. Global Immunoglobulin Revenue Market Share by Application in 2019
Figure 29. North America Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Immunoglobulin Sales Market Share by Country in 2019
Figure 32. North America Immunoglobulin Revenue Market Share by Country in 2019
Figure 33. U.S. Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Immunoglobulin Market Share by Type in 2019
Figure 38. North America Immunoglobulin Market Share by Application in 2019
Figure 39. Europe Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Immunoglobulin Sales Market Share by Country in 2019
Figure 42. Europe Immunoglobulin Revenue Market Share by Country in 2019
Figure 43. Germany Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Immunoglobulin Market Share by Type in 2019
Figure 54. Europe Immunoglobulin Market Share by Application in 2019
Figure 55. Asia Pacific Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Immunoglobulin Sales Market Share by Region in 2019
Figure 58. Asia Pacific Immunoglobulin Revenue Market Share by Region in 2019
Figure 59. China Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Immunoglobulin Market Share by Type in 2019
Figure 82. Asia Pacific Immunoglobulin Market Share by Application in 2019
Figure 83. Latin America Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Immunoglobulin Sales Market Share by Country in 2019
Figure 86. Latin America Immunoglobulin Revenue Market Share by Country in 2019
Figure 87. Mexico Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Immunoglobulin Market Share by Type in 2019
Figure 94. Latin America Immunoglobulin Market Share by Application in 2019
Figure 95. Middle East and Africa Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Immunoglobulin Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Immunoglobulin Revenue Market Share by Country in 2019
Figure 99. Turkey Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Immunoglobulin Market Share by Type in 2019
Figure 106. Middle East and Africa Immunoglobulin Market Share by Application in 2019
Figure 107. North America Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
ヒトB型肝炎免疫グロブリンの世界市場（～2026年） Market Analysis and Insights: Global Human Hepatitis B Immunoglobulin Market The global Human Hepatitis B Immunoglobulin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Hepatitis B Immunoglobulin Scope and Market…- 低親和性免疫グロブリンガンマFc領域受容体II-bの世界市場（～2026年） Market Analysis and Insights: Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market The global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global…
- 免疫グロブリン製品の世界市場（～2026年） Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. …
- ヒト血漿由来治療薬の世界市場（～2026年） Market Analysis and Insights: Global Human Plasma-Derived Therapeutics Market The global Human Plasma-Derived Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Plasma-Derived Therapeutics Scope and Mar…
- 特発性血小板減少性紫斑病（ITP）治療薬の世界市場（～2026年） ITP (idiopathic thrombocytopenic purpura) is a rare disease with low affliction rates. This disease leads to excessive bruising or bleeding due to the lack of blood platelets. It is also known as immune thrombocytopenia and can affect children and adults alike. Increasing demand for combination ther…